Chemotherapeutic drug activation of the AP24 protease in apoptosis: requirement for caspase 3-like-proteases.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  1998-04-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/BBRC.1998.8508PMID 9588194
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD

  1998cited by this paper
• The Central Executioner of Apoptosis: Multiple Connections between Protease Activation and Mitochondria in Fas/APO-1/CD95- and Ceramide-induced Apoptosis

  1997cited by this paper
• Caspases: killer proteases.

  1997cited by this paper
• Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents.

  1997cited by this paper
• Apoptosis: alive and kicking in 1997.

  1997cited by this paper
• Two different proteases are involved in the proteolysis of lamin during apoptosis.

  1997cited by this paper
• Calmodulin‐dependent protein kinase II mediates signal transduction in apoptosis

  1997cited by this paper
• Biochemical characterization of the protein activity responsible for high molecular weight DNA fragmentation during drug-induced apoptosis.

  1997cited by this paper
• Activation of CPP32-like Proteases Is Not Sufficient to Trigger Apoptosis: Inhibition of Apoptosis by Agents that Suppress Activation of AP24, but Not CPP32-like Activity

  1997cited by this paper
• Apoptosis and response to radiation: implications for radiation therapy.

  1997cited by this paper
• Serine protease inhibitors block neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin

  1997cited by this paper
• Involvement of cytoplasmic serine proteinase and CPP32 subfamily in the molecular machinery of caspase 3 activation during Fas-mediated apoptosis.

  1997cited by this paper
• Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents.

  1996cited by this paper
• Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32.

  1996cited by this paper
• Proteolytic cleavage during chemotherapy-induced apoptosis.

  1996cited by this paper
• The role of proteases during apoptosis

  1996cited by this paper
• Calcium-dependent, Interleukin 1β-converting Enzyme Inhibitor-insensitive Degradation of Lamin B1 and DNA Fragmentation in Isolated Thymocyte Nuclei*

  1996cited by this paper
• Pivotal role of a DEVD‐sensitive step in etoposide‐induced and Fas‐mediated apoptotic pathways.

  1996cited by this paper
• Intracellular signaling pathways involved in the induction of apoptosis in immature thymic T lymphocytes.

  1996cited by this paper
• Biochemical pathways of apoptosis: nicotinamide adenine dinucleotide- deficient cells are resistant to tumor necrosis factor or ultraviolet light activation of the 24-kD apoptotic protease and DNA fragmentation

  1996cited by this paper
• ICE family proteases: mediators of all apoptotic cell death?

  1996cited by this paper
• Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 24 kDa apoptotic protease (AP24)

  1996cited by this paper
• Proteolysis and the biochemistry of life-or-death decisions

  1996cited by this paper
• Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis.

  1995cited by this paper
• Protease activation during apoptosis: death by a thousand cuts?

  1995cited by this paper
• Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

  1995cited by this paper
• Apoptosis in the pathogenesis and treatment of disease

  1995cited by this paper
• Aspartate-based inhibitor of interleukin-1 beta-converting enzyme prevents antitumor agent-induced apoptosis in human myeloid leukemia U937 cells.

  1995cited by this paper
• Inhibition of Nuclear Translocation of Transcription Factor NF-κB by a Synthetic Peptide Containing a Cell Membrane-permeable Motif and Nuclear Localization Sequence (*)

  1995cited by this paper
• A pre‐existing protease is a common effector of thymocyte apoptosis mediated by diverse stimuli

  1995cited by this paper
• Nuclear serine protease activity contributes to bile acid-induced apoptosis in hepatocytes.

  1995cited by this paper
• Isolation and partial characterization of a protease involved in Fas‐induced apoptosis

  1995cited by this paper
• Formation of 50 kbp chromatin fragments in isolated liver nuclei is mediated by protease and endonuclease activation

  1994cited by this paper
• Purification of a 24-kD protease from apoptotic tumor cells that activates DNA fragmentation

  1994cited by this paper
• Anchorage dependence, integrins, and apoptosis.

  1994cited by this paper
• Inhibition of apoptosis as a mechanism of tumor promotion

  1994cited by this paper
• Apoptosis and DNA fragmentation precede TNF‐induced cytolysis in U937 cells

  1992cited by this paper
• Antimetastatic activity of boro-amino acid analog protease inhibitors against B16BL6 melanoma in vivo.

  1992cited by this paper
• Apoptosis in the genesis and prevention of cancer.

  1992cited by this paper
• Social controls on cell survival and cell death

  1992cited by this paper
• Programmed cell death: apoptosis and oncogenesis.

  1991cited by this paper
• Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia.

  1990cited by this paper
• Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note.

  1989cited by this paper
• Inhibition of radiation-induced apoptosis in vitro by tumor promoters.

  1988cited by this paper
• Acylamino boronic acids and difluoroborane analogues of amino acids: potent inhibitors of chymotrypsin and elastase.

  1985cited by this paper

• Activation of DNA-degrading enzymes during apoptosis.

  2009cites this paper
• Arguments en faveur de l'existence d'une activité pro-apoptotique des lamellarines vis-à-vis des cellules tumorales par ciblage mitochondrial

  2009cites this paper
• Novel analogues of CC-1065 and the duocarmycins for the use in targeted tumour therapies.

  2009cites this paper
• Caspase-independent pathways of programmed cell death: the unraveling of new targets of cancer therapy?

  2009cites this paper
• Involvement of Chymotrypsin-Like Serine Proteases in Cell Death Processes

  2008cites this paper
• Signaling Molecules in Sulfur Mustard-Induced Cutaneous Injury

  2007cites this paper
• A more serine way to die: defining the characteristics of serine protease-mediated cell death cascades.

  2007cites this paper
• Activation of an alternative death receptor-induced signaling pathway in human hepatocytes under caspase arrest.

  2007cites this paper
• Adenine-N3 in the DNA minor groove - an emerging target for platinum containing anticancer pharmacophores.

  2007cites this paper
• Activation of U937 Cells by Contact Sensitizers: CD86 Expression is Independent of Apoptosis

  2006cites this paper
• Caspase-dependant activation of chymotrypsin-like proteases mediates nuclear events during Jurkat T cell apoptosis.

  2006cites this paper
• Measurement of two caspase activities simultaneously in living cells by a novel dual FRET fluorescent indicator probe

  2006cites this paper
• Calmodulin mediates sulfur mustard toxicity in human keratinocytes.

  2006cites this paper
• Tumor Resistance to Apoptosis

  2004cites this paper
• A Serine Protease-Dependent Mechanism of Apoptosis after Caspase Arrest

  2004cites this paper
• Monitoring caspase activity in living cells using fluorescent proteins and flow cytometry.

  2004cites this paper
• In the cut and thrust of apoptosis, serine proteases come of age.

  2003cites this paper
• Synthesis and cytotoxicity of a biotinylated CC-1065 analogue

  2002cites this paper
• Triggering caspase-independent cell death to combat cancer.

  2002cites this paper
• Activation of chymotrypsin-like serine protease(s) during apoptosis detected by affinity-labeling of the enzymatic center with fluoresceinated inhibitor.

  2002cites this paper
• Caspase inhibitors as anti-inflammatory and antiapoptotic agents.

  2002cites this paper
• Sequential Activation of Caspases and Serine Proteases (Serpases) During Apoptosis

  2002cites this paper
• Inhibitors of trypsin-like serine proteases prevent DNA damage-induced neuronal death by acting upstream of the mitochondrial checkpoint and of p53 induction.

  2001cites this paper
• Synthesis and preliminary cytotoxicity study of a cephalosporin-CC-1065 analogue prodrug

  2001cites this paper
• Se-methylselenocysteine induces apoptosis through caspase activation in HL-60 cells.

  2001cites this paper
• Synthesis and preliminary biological evaluations of CC-1065 analogues: effects of different linkers and terminal amides on biological activity.

  2000cites this paper
• Ectopic expression of Bcl-2 switches over nuclear signalling for cAMP-induced apoptosis to granulocytic differentiation

  2000cites this paper
• DNases and apoptosis.

  2000cites this paper
• An Apoptosis Regulator isolated from Petasites japonicum.

  2000cites this paper
• Nuclear translocation of a leukocyte elastase Inhibitor/Elastase complex during staurosporine-induced apoptosis: role in the generation of nuclear L-DNase II activity.

  2000cites this paper
• The Novel Synthetic Retinoid 6-(3-adamantyl-4-hydroxyphenyl)-2-naphthalene Carboxylic Acid (CD437) Causes Apoptosis in Acute Promyelocytic Leukemia Cells Through Rapid Activation of Caspases

  1999cites this paper
• Caspase inhibitors - A chemist's perspective

  1999cites this paper
• Mammalian caspases: structure, activation, substrates, and functions during apoptosis.

  1999cites this paper
• Caspase-mediated Cleavage of DNA Topoisomerase I at Unconventional Sites during Apoptosis*

  1999cites this paper
• In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RARα protein and the PML retargeting on PML-nuclear bodies

  1999cites this paper
• The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases.

  1999cites this paper
• Bcl-2-mediated resistance to apoptosis is associated with glutathione-induced inhibition of AP24 activation of nuclear DNA fragmentation.

  1998cites this paper